|
$4,383,123
|
To build a program that communicates evidence-based methodologies for drug pricing and payment.
|
2015 - 2019
|
LJAF
|
|
$5,492,419
|
To support Grantee's continued efforts to communicates viable, evidence-based methodologies and solutions to drug pricing that balance patient affordability with sustained incentives for innovation.
|
2019 - 2022
|
LJAF
|
